When depression fails to respond to traditional treatments, innovative solutions like Spravato offer real hope and effectiveness.

For many individuals, depression can endure despite trying various medications, which can undoubtedly be disheartening. However, Spravato® presents a promising alternative. By targeting the brain's glutamate system, it enhances neural connectivity and mood regulation, marking a significant advancement in our approach to treating depression.

What Is Spravato?

Spravato is an FDA-approved nasal spray administered in a certified medical setting under supervision.

It may be considered for individuals with treatment-resistant depression or certain forms of major depressive disorder.

What Makes It Different?

Traditional antidepressants primarily affect serotonin.

Spravato targets glutamate pathways, which are believed to influence synaptic plasticity — the brain’s ability to form and strengthen connections.

This mechanism represents a new therapeutic direction in psychiatry.

❓ FAQ

Is Spravato the same as ketamine infusions?No. Spravato is an FDA-approved nasal esketamine formulation with specific protocols.

How is it administered? Under medical supervision in-office.

Is everyone eligible?No. Evaluation is required to determine appropriateness.

Considering a New Direction?

Schedule a consultation to determine whether Spravato may be appropriate for you.

📞 240-266-5889🌐 www.dmvpsychiatricwellness.com

[Request Information]